KRAS and familial pancreatic carcinoma: Other approaches to achieve extrahepatic delivery include direct local instillation, e.g., surgical implantation of depot delivery systems such as anti-KRAS siRNA in the “LODER “device for pancreatic cancer [18] or intrathecal injection of mRNA splice modifying ASOs for spinal muscular atrophy [9].